Edition:
United Kingdom

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

1.78USD
17 Aug 2018
Change (% chg)

$-0.13 (-6.81%)
Prev Close
$1.91
Open
$1.95
Day's High
$1.98
Day's Low
$1.63
Volume
12,340
Avg. Vol
13,024
52-wk High
$3.92
52-wk Low
$1.16

Latest Key Developments (Source: Significant Developments)

Biolase Q2 Non-Gaap Loss Per Share $0.20
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - BIOLASE Inc ::BIOLASE REPORTS 2018 SECOND QUARTER RESULTS.Q2 NON-GAAP LOSS PER SHARE $0.20.Q2 LOSS PER SHARE $0.24.Q2 REVENUE ROSE 1 PERCENT TO $12.2 MILLION.AS OF JUNE 30, 2018, HAD ABOUT $14.4 MILLION IN WORKING CAPITAL.CASH AND RESTRICTED CASH TOTALED $3.1 MILLION ON JUNE 30, 2018, AS COMPARED TO $11.9 MILLION ON DEC 31, 2017.  Full Article

BIOLASE Names Todd A. Norbe President, Chief Executive Officer
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - BIOLASE Inc ::BIOLASE NAMES TODD A. NORBE PRESIDENT, CHIEF EXECUTIVE OFFICER.BIOLASE INC - JOHN R. BEAVER PROMOTED TO EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER.  Full Article

Biolase Announces 1-For-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11
Thursday, 10 May 2018 

May 10 (Reuters) - BIOLASE Inc ::BIOLASE ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON MAY 11.BIOLASE INC - 1-FOR-5 REVERSE STOCK SPLIT WILL BECOME EFFECTIVE AT 11:59 P.M. ET ON THURSDAY, MAY 10, 2018.  Full Article

Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives
Wednesday, 11 Apr 2018 

April 11 (Reuters) - BIOLASE Inc ::HAS ASKED JONATHAN T. LORD CHAIRMAN OF BOARD OF BIOLASE, TO LEAD CO'S EXPLORATION OF STRATEGIC ALTERNATIVES.BOARD HAS ALSO APPOINTED CHIEF FINANCIAL OFFICER JOHN BEAVER AS INTERIM CHIEF EXECUTIVE OFFICER.BEAVER REPLACES HAROLD FLYNN, JR., WHO HAS RESIGNED FROM HIS POSITIONS AS PRESIDENT AND CHIEF EXECUTIVE OFFICER.STRATEGIC ALTERNATIVES MAY INCLUDE A MERGER OR OTHER BUSINESS COMBINATION WITH ANOTHER PARTY.  Full Article

Biolase Files For Possible Resale Of Up To 21.9 Mln Shares Of Common Stock By Selling Stockholders
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Biolase Inc ::BIOLASE INC FILES FOR POSSIBLE RESALE OF UP TO 21.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Biolase reports Q3 non-GAAP loss per share $0.05
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Biolase Inc :Biolase reports 2017 third quarter and nine-month results.Q3 non-GAAP loss per share $0.05.Q3 loss per share $0.06.Q3 revenue rose 18 percent to $10.8 million.  Full Article

Biolase appoints Richard Lanman to board of directors
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Biolase Inc ::Biolase appoints Richard B. Lanman to board of directors.Biolase - ‍Lanman replaces outgoing director Fredrick Moll​.  Full Article

BRIEF-Biolase Announces 1-For-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11

* BIOLASE ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON MAY 11